METACRINE

YTD

ALL

Why Robinhood?

You can watch METACRINE and buy or sell other stocks, ETFs, and their options commission-free!

About MTCR

Metacrine is a clinical-stage biopharmaceutical company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases. The most advanced program is focused on the farnesoid X receptor (FXR) an important drug target in multiple liver and GI diseases.

CEO

Dave Maggio

CEODave Maggio

Employees

—

Employees—

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2014

Founded2014

Employees

—

Employees—

MTCR Key Statistics

Market cap

24.75M

Market cap24.75M

Price-Earnings ratio

-0.57

Price-Earnings ratio-0.57

Dividend yield

—

Dividend yield—

Average volume

54.81K

Average volume54.81K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.5905

52 Week high$0.5905

52 Week low

$0.303

52 Week low$0.303

People also own

Based on the portfolios of people who own MTCR. This list is generated using Robinhood data, and it’s not a recommendation.

Cenntro Electric Group Li…